Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07364851

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

A Randomized, Open-label, Single-dose, 2-sequence, Two-period, Crossover Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Administration of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
38 (estimated)
Sponsor
Daewon Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

Safety and pharmacokinetic characteristics evaluation of DW4421-T1 and DW4421S-T1

Conditions

Interventions

TypeNameDescription
DRUGDW4421-T1DW4421-T1 or DW4421S-T1
DRUGDW4421S-T1DW4421-T1 or DW4421S-T1

Timeline

Start date
2026-03-06
Primary completion
2026-05-30
Completion
2026-08-30
First posted
2026-01-23
Last updated
2026-01-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07364851. Inclusion in this directory is not an endorsement.